Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Antibodies. Found 21 abstracts

no pagination
Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, Weitzner BD, Hu X, Adachi Y, Schief WR, Dunbrack RL. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design. PLoS computational biology. 2018 Apr 27;14(4):e1006112.   PMCID: PMC5942852
Lyu Z, Kang L, Buuh ZY, Jiang D, McGuth JC, Du J, Wissler HL, Cai W, Wang RE. A Switchable Site-Specific Antibody Conjugate. ACS chemical biology. 2018 Apr 20;13(4):958-64.   PMCID: PMC5910183
Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, West WW, Wu H, Roden AC, Fujimoto J, Yu H, Anders R, Kowalewski A, Rivard C, Rehman J, Batenchuk C, Burns V, Hirsch FR, Wistuba. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017 Aug;3(8):1051-8.   PMCID: PMC5650234
Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B, Zhang T, Ma X, Li X, Ma C, Su W, Wang Y, Qin X, Liang S. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice. Sci Rep. 2016 Jul 22;6:30239.   PMCID: PMC4957234
Ji W, Arnst C, Tipton AR, Bekier ME, Taylor WR, Yen TJ, Liu ST. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases. PLoS One. 2016 Jan;11(4):e0153518.   PMCID: PMC4833387
Ji W, Arnst C, Tipton AR, Bekier ME, Taylor WR, Yen TJ, Liu ST. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases. PLoS One. 2016 Jan;11(4):e0153518.   PMCID: PMC4833387
Anikeeva N, Steblyanko M, Fayngerts S, Kopylova N, Marshall DJ, Powers GD, Sato T, Campbell KS, Sykulev Y. Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European Journal of Immunology. 2014 Aug;44(8):2331-9.   PMCID: 4141007
Larrick JW, Parren P, Huston JS, Pluckthun A, Bradbury A, Tomlinson IM, Chester KA, Burton DR, Adams GP, Weiner LM, Scott JK, Alfenito MR, Veldman T, Reichert JM. Antibody engineering and therapeutics conference The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014. Mabs. 2014 Sep;6(5):1115-23.   PMCID: 4622443
Purdy AK, Alvarez Arias DA, Oshinsky J, James AM, Serebriiskii I, Campbell KS. The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells. J Immunol. 2014 Nov;193(9):4675-83.   PMCID: 4269369
Jiang WD, Huang RC, Duan CH, Fu LW, Xi Y, Yang YB, Yang WM, Yang DZ, Yang DH, Huang RP. Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays. Plos One. 2013 Oct;8(10):e76795.   PMCID: PMC 3792870
North B, Lehmann A, Dunbrack RL. A new clustering of antibody CDR loop conformations. J Mol Biol. 2011 Feb 18;406(2):228-56.   PMCID: PMC3065967
Yuan QA, Robinson MK, Simmons HH, Russeva M, Adams GP. Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning. Cancer immunology, immunotherapy : CII. 2008 Mar;57(3):367-78.
Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002 Aug 15;62(16):4767-72.
Fashena SJ, Einarson MB, O'Neill GM, Patriotis C, Golemis EA. Dissection of HEF1-dependent functions in motility and transcriptional regulation. Journal of cell science. 2002 Jan;115(Pt 1):99-111.
Babb JS, Rogatko A. Patient specific dosing in a cancer phase I clinical trial. Statistics in medicine. 2001 Jul 30;20(14):2079-90.
Campbell MS, Chan GK, Yen TJ. Mitotic checkpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase. Journal of cell science. 2001 Mar;114(Pt 5):953-63.
Einarson MB, Estojak J, Serebriiskii I, Golemis EA. HEI-C encoding nucleic acids, polypeptides, antibodies and methods of uses thereof. 2001 Jun 20;:83 pp.
Marmorstein LY, Kinev AV, Chan GK, Bochar DA, Beniya H, Epstein JA, Yen TJ, Shiekhattar R. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell. 2001 Jan 26;104(2):247-57.
Yeung AT. Polynucleotides encoding mismatch endonuclease CELI and diagnostic and therapeutic uses thereof. 2001 Feb 22;:93 pp.
Weiner LM, Adams GP. New approaches to antibody therapy. Oncogene. 2000 Dec 11;19(53):6144-51.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Antibodies

Antibodies immunology genetics metabolism chemistry Human Non-US Gov't Support physiology methods US Gov't Support-PHS Amino Acid Sequence Mice pharmacology pathology antagonists & inhibitors Animal Mitosis Molecular Sequence Data Neoplasms Protein Conformation Female HeLa Cells Protein sequences Adenocarcinoma Inflammation Aurora Kinase B MCF-7 Cells Reproducibility of Results Protein-Serine-Threonine Kinases Natural Killer Cells Kinetochores blood Molecular Cloning US Gov't Support-Non-PHS Ovarian Neoplasms Centromere Protein Engineering Protein Kinase Inhibitors Complementarity Determining Regions therapeutic use therapy Sensitivity and Specificity Genetic polymorphism Monoclonal Antibodies Enzyme-Linked Immunosorbent Assay Diagnosis (mol Transfection Breast Neoplasms diagnosis Signal Transduction M Phase Cell Cycle Checkpoints Phosphoproteins Drug screening drug effects Cell Line Hela Cells Naphthyridines Immunologic Cytotoxicity DNA sequence analysis Protein Binding Tertiary Protein Structure Immunoglobulin Variable Region Diagnosis 4-nucleotide Mutation (deletion Up-Regulation diagnostic imaging Complement Membrane Attack Complex Immunologic Factors Lung Neoplasms cDNA sequence Apium celery CEL I endonuclease Immunoglobulin Heavy Chains Flow Cytometry KIR Receptors Clone Cells Passive Immunization Hemolysis Mutation classification Research Design Platelet-Derived Growth Factor alpha Receptor Shock Drugs Antigen-Antibody Reactions Bacteriophages formation Animal tissue (aberrant unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (MAP (microtubule-assocd protein)-HEI-C Adcc Radioimmunotherapy Adult Microarray Analysis NK cells THU (Therapeutic use) DNA Role: ANT (Analyte)-ANST (Analy Western Blotting of HEI-C Coiled-coil (domain Middle Aged Molecular cloning RNA Endocytosis Integrin alphaV polypeptides cDNA sequences (HEI-C encoding nucleic acids-antibodies and methods of uses thereof) Complement C9 toxicity Drug Delivery Systems KIR3DL1 Receptors bispecific antibody Recombinant Fusion Proteins Molecular Models Peptide Library Monte Carlo Method Switch Genes Neural Networks (Computer) antibody-drug conjugate Binding Sites Non-Small-Cell Lung Carcinoma Fungi Oligonucleotide Array Sequence Analysis BSU (Biological study Probes Role: ARG (Analytical reagent use)-unclassified)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (HEI-C encoding nucleic acids-polypeptides-antibodies and methods of uses thereof) Serine Endopeptidases Immunohistochemistry Kinetics purification Complement C5b B7-H1 Antigen Tumor Biomarkers Animal Disease Models Neoplasm THU (Therapeutic use) Gene Role: ANT (Analyte)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (BRCA1-detection of mutations Nuclear Pore IgG Receptors Antibody Specificity Complement System Proteins Growth Substances unclassified) Gene Role: BUU (Biological use-BIOL (Biological study)-USES (Uses) (for CEL I endonuclease Tetracycline DNA-Binding Proteins Proteomics Histocompatibility Antigens Class I Protein Transport Mitogen-Activated Protein Kinases Cell nucleus Erythrocytes Biological Assay Genotyping Microinjections Neoplasm Antibodies polypeptides HEI-C encoding nucleic acids-antibodies and methods of uses thereof) unclassified) Gene Role: BUU (Biological use-BIOL (Biological study)-USES (Uses) (for ZEN1 endonuclease-diagnostic and therapeutic uses Algorithms physiopathology Neoplastic Gene Expression Regulation
Last updated on Saturday, June 06, 2020